Member Info for JohnHenry

Whimax they can only buy and sell the trade on the same exchange, so makes SFA difference.

NAS is also an order driven market. US will slowly grind down to UK levels. Aimho

David Budd, Chief Executive Officer of genedrive plc, said "We are very pleased to have the opportunity to work with Beckman Coulter in delivering an innovative high throughput COVID-19 PCR solution. It's been our focus to work with a top tier, high throughput lab automation partner like Beckman to drive uptake of our test and further differentiate our unique capabilities in the market. The combination of our ready to use chemistry with robotics and on-board RNA extraction would give laboratories a unique and rapid workflow that can achieve impressive throughput and result turnaround times. We are both working to have the ongoing validation completed in approximately 6 WEEKS, with initial introduction in the USA at an already identified clinical laboratory."

Whimax, US has SFA volume, will return to the UK price eventually.

Groover GDR is not imbedded into the UK testing system.

Nothing to do with the herd selling then. D***

Budds business model is failing imho. GDRs USP has disappeared.

Worth remember both NCYT and ODX lost 10% on their results.

I expect GDR to be trading in the 40s tomorrow.

here

Was talking to the owner yesterday of a private company heavily involved in UK testing.

Mass testing will be hear until at least next winter. his words.

Interesting his take on the new Mink mutation, in a nut shell the new vaccines wouldnt work.

Just gets better and better. simply streets ahead of other testing stocks.

worth noting theres a S hit load more shares in issue today.

shorts closing and traders speculating.
If the Guardian article comes to fruition then ouch

Chat is being switched off as the platform can no longer support the increase in data

Jayejordan i suggest you do some homework on viruses, You cant cure a virus, antibiotics dont work you can only treat the symptoms.

news knocking the ST out of NCYT

As expected Accustem now being discounted from the TILS SP in the US. Will be interesting to see how low the US will move the price down.

Get real 100k buy is hardly going to knock £25 million from the market cap

Fishboy1000 go get ready for school

Whimax the ADR instrument hasn’t gone ex record, therefore any purchase of ADR S means you are still entitled to the demerger stock , hence is still priced into the ADR.

Like I said earlier the demerger process has been a complete CF

Depository Receipts (DR) are instruments derived from another underlying instrument while Multi-listed instruments represent the actual stock of a company. DR are convertible back to ordinary shares, following a process dependent upon the sponsoring facility that created the instrument. Ownership of a DR does not convey the same rights as a direct holder of equity shares, but in most cases the DR is convertible back into the original instrument through a process of conversion. The DR receive a different ISIN number, recognizing that they are not the same fungible instrument as the underlying stock. Popular DR include American Depositary Receipts (ADR), European Depositary Receipts (EDR), global depository receipts (GDR, also referred to as international depository receipts), and Global Registered Shares (GRS).